Targeting Neuronal Transcription Factor BRN2 in Neuroendocrine Tumors

Ravi Munuganti; Daksh Thaper; Sahil Kumar; Soojin Kim; Olena Sivak; Amina Zoubeidi

doi:10.3390/proceedings2019022090

Proceedings (Aug 2019)

Targeting Neuronal Transcription Factor BRN2 in Neuroendocrine Tumors

Ravi Munuganti,
Daksh Thaper,
Sahil Kumar,
Soojin Kim,
Olena Sivak,
Amina Zoubeidi

Affiliations

Ravi Munuganti: Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, BC V6H3Z6, Canada
Daksh Thaper: Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, BC V6H3Z6, Canada
Sahil Kumar: Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, BC V6H3Z6, Canada
Soojin Kim: Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, BC V6H3Z6, Canada
Olena Sivak: Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, BC V6H3Z6, Canada
Amina Zoubeidi: Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, BC V6H3Z6, Canada

DOI: https://doi.org/10.3390/proceedings2019022090
Journal volume & issue: Vol. 22, no. 1
p. 90

Abstract

Read online

No targeted therapies exist against aggressive neuroendocrine tumors; hence, these patients are limited to platinum-based chemotherapy that has not advanced in over three decades. [...]

Published in Proceedings

ISSN: 2504-3900 (Online)
Publisher: MDPI AG
Country of publisher: Switzerland
LCC subjects: General Works
Website: http://www.mdpi.com/journal/proceedings

About the journal

Abstract

Keywords